Skip to content

The Carlyle Group CG Global Market Strategies — Goodwill Impairment

Discontinued — last reported Q4 '15

Similar metrics at other companies

GameStop logo
GMEUnited States — Goodwill Impairment
$90.98M-54.3%
Equitable Holdings logo
EQHCorporate And Other — Goodwill Impairment
$0-100%
Jefferies Financial Group logo
JEFAsset Management — Goodwill, Impairment Loss
$58.24M
AWK
AWKMarket Based Businesses — Goodwill Impairment
$53M
IES
IESCCorporate Segment — Goodwill impairment expense
$0
Popular logo
BPOPOperating Segments — Goodwill Impairment

Other financials

Income statement

See full
Revenue$254.0M-73.9%
Net income-$132.2M-202%
EPS (diluted)-$0.37-206%

Balance sheet

See full
Cash & equivalents$1.7B+40.3%
Total debt$466.8M-6.8%
Total equity$7.4B+15.5%
Total assets$29.8B+23.8%

Cash flow

See full
Operating cash flow-$1.2B-253%
CapEx$28.1M+68.3%
Free cash flow-$1.3B-244%

Valuation

See full
Market cap$16.13B+11.0%
Enterprise value$14.91B+8.1%
P/E29.5×+16.1×
P/S+1.4×

Profitability

See full
Net margin13.5%-5.5pp
FCF margin-105.3%

Returns & leverage

See full
Return on equity7.9%-9.9pp
Debt / equity0.1×0.0×

Where this comes from

Reported directly by The Carlyle Group in its filing.

Tagged under the XBRL concept us-gaap:GoodwillImpairmentLoss.

The official record: The Carlyle Group’s 10-K, filed February 24, 2016, on SEC EDGAR. View the filing →

Questions, answered.

What does global market strategies — goodwill impairment mean?
The reduction in the recorded value of goodwill for the Global Market Strategies segment due to a decline in the segment's fair value.
How do you interpret global market strategies — goodwill impairment?
An increase indicates a loss of value in past acquisitions, suggesting potential overpayment or deteriorating performance in the segment's underlying assets.
How does global market strategies — goodwill impairment compare across companies?
Peers in alternative asset management report similar charges as 'Goodwill Impairment' or 'Asset Impairment' within their segment disclosures, often triggered by annual impairment testing or adverse market events.